Physician profile
Rhett Daugherty
NPI 1679544365
$8,073.46
in general payments reported to CMS, 2019-2025
50 companies · $1,615 in 2025
The $1,615 reported for 2025 was more than what 75% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,580 · 2020: $184 · 2021: $360 · 2022: $1,651 · 2023: $1,195 · 2024: $1,488 · 2025: $1,615.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,297.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,297.30 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Neotract INC. | $1,053.14 | 2019 | |
| Abbvie INC. | $787.74 | 2022-2025 | Botox, Lupron Depot |
| Janssen Biotech, INC. | $593.97 | 2019-2025 | Erleada |
| Astellas Pharma US INC | $588.60 | 2019-2025 | Xtandi, Veozah |
| Pfizer INC. | $554.65 | 2019-2025 | |
| Progenics Pharmaceuticals, INC. | $439.24 | 2022-2025 | Pylarify |
| Sumitomo Pharma America, INC. | $403.04 | 2023-2025 | Orgovyx, Gemtesa |
| Urogen Pharma, INC. | $273.25 | 2022-2025 | Jelmyto |
| Antares Pharma, INC. | $260.12 | 2019-2025 | Xyosted, Tlando, Nocdurna |
| Bayer Healthcare Pharmaceuticals INC. | $245.51 | 2019-2025 | |
| Teleflex LLC | $242.14 | 2022-2025 | Urolift |
| Medtronic, INC. | $236.56 | 2022-2024 | Interstim |
| Tolmar, INC. | $198.52 | 2023-2025 | Jatenzo, Eligard |
| Urovant Sciences INC | $174.13 | 2021-2022 | |
| Myriad Genetic Laboratories, INC. | $161.48 | 2021-2024 | Prolaris |
Show all 50 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axonics, INC. | $156.81 | 2021-2024 | Axonics |
| Merck Sharp & Dohme LLC | $149.05 | 2019-2024 | Lynparza, Keytruda, Welireg |
| Ferring Pharmaceuticals INC. | $134.95 | 2019-2025 | Adstiladrin |
| Dendreon Pharmaceuticals LLC | $124.13 | 2022-2025 | Provenge |
| Endo USA, INC. | $118.44 | 2024-2025 | Xiaflex, Aveed |
| Tolmar Pharmaceuticals, INC. | $102.89 | 2019-2022 | |
| Allergan, INC. | $100.85 | 2019-2022 | |
| Procept Biorobotics Corporation | $89.73 | 2020 | |
| Myovant Sciences INC. | $80.95 | 2021-2022 | |
| Novartis Pharmaceuticals Corporation | $71.96 | 2024-2025 | |
| Olympus America INC. | $67.03 | 2023-2025 | Itind System |
| Endo Pharmaceuticals INC. | $60.75 | 2019-2024 | Xiaflex, Aveed |
| Tempus Ai, INC | $59.12 | 2024-2025 | Xt Cdx |
| Lantheus Medical Imaging, INC. | $51.96 | 2024 | |
| Bioprotect Medical, INC. | $48.87 | 2025 | Bioprotect Balloon Implant System |
| Amgen INC. | $48.21 | 2019-2023 | Prolia |
| Zyla Life Sciences, INC. | $37.23 | 2019 | |
| Boston Scientific Corporation | $33.69 | 2024-2025 | Spaceoar Vue System - 10ml, Rezum Generator |
| Photocure INC | $32.02 | 2019-2024 | Cysview |
| Coloplast Corp | $31.31 | 2023-2024 | Porges Coloplast |
| Laborie Medical Technologies Corp. | $26.36 | 2025 | Endosheath Technology |
| Blue Earth Diagnostics | $23.81 | 2023 | |
| Novo Nordisk INC | $22.52 | 2024 | Rivfloza |
| Cook Medical LLC | $22.37 | 2025 | Litho 150 |
| Rochester Medical Corporation | $19.23 | 2021 | |
| Halozyme INC | $18.55 | 2023 | |
| Alnylam Pharmaceuticals INC. | $16.88 | 2023 | Givlaari |
| Acerus Pharmaceuticals Corporation | $16.81 | 2022 | |
| Caris Mpi, INC. | $15.92 | 2025 | Mi Cancer Seek |
| Therapeuticsmd, INC. | $14.64 | 2019 | |
| Clarus Therapeutics INC. | $14.26 | 2021 | |
| Foundation Medicine, INC. | $14.19 | 2020 | |
| Medtronic USA, INC. | $12.41 | 2019 | |
| Metuchen Pharmaceuticals | $11.78 | 2019 | |
| Aytu Biopharma, INC. | $11.69 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rhett Daugherty listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.